Relationship between OprD porin downregulation and in-vitro interactions in Pseudomonas aeruginosa
DOI:
https://doi.org/10.3855/jidc.22217Keywords:
Pseudomonas aeruginosa, OprD, porin, antimicrobial synergyAbstract
Introduction: OprD porin plays a critical role in antibiotic uptake. However, the role of OprD in antimicrobial interactions is not yet fully understood. This study investigated the relationship between OprD downregulation and in vitro interactions of meropenem (MEM) with combinations of colistin (CT), ertapenem (ETP), and fosfomycin (FF) in Pseudomonas aeruginosa.
Methodology: A total of 40 P. aeruginosa isolates were included in the study and divided into two groups (group-1, 20 isolates with confirmed OprD suppression; group-2; 20 isolates without OprD suppression). Antimicrobial interactions were examined using the checkerboard method.
Results: The synergy rates of MEM/CT, MEM/ETP, and MEM/FF combinations in group-1/group-2 isolates were determined as 45%/30%, 5%/5%, and 15%/10% respectively. The minimum inhibitory concentration (MIC) of antimicrobials in combinations were examined for group-1 and group-2 isolates, and a decrease of 90%, 90% for MEM and 70%, 40% for CT was detected in the MEM/CT combination, 50%, 45% for MEM and 35%, 40% for ETP in the MEM/ETP combination, and 35%, 20% for MEM and 55%, 45% for FF in the MEM/FF combination, respectively.
Conclusions: While significant synergy was observed between MEM/CT in OprD-deficient isolates, the limited synergistic effects observed with other combinations, such as MEM/ETP and MEM/FF, suggest that the impact of OprD downregulation on antimicrobial resistance is multifactorial and complex. The findings suggest that CT, when combined with MEM, may overcome certain resistance mechanisms mediated by OprD downregulation. Further investigations incorporating molecular diagnostics and in vivo validation are warranted to fully elucidate the therapeutic potential of these combinations.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Tuba Muderris, Ufuk Akbayırlı, Rıza Durmaz, Selçuk Kaya, Tuba Dal, Ziya Cibali Açıkgöz, Ayşegül Aksoy Gökmen

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

